- Profesionales
- Research
- Studies/Publications
- HER2 positive Breast Cancer
- Adjuvant
- Closed in follow up
- GEICAM/2010-11_APHINITY
HER2 positive Breast Cancer
GEICAM/2010-11_APHINITY
A randomized multicenter, double-blind, placebo-controlled comparison of chemotherapy plus Trastuzumab plus placebo versus chemotherapy plus Trastuzumab plus Pertuzumab as adjuvant therapy in patients with operable HER2+ primary Breast Cancer
Medical Coordinator:
Dr. Alvaro Rodríguez-Lescure & Dr. Manuel Ruiz Borrego
Included Patients:
247
Global:
4806
Sponsor:
BIG Breast International Group
Link:
https://clinicaltrials.gov/ct2/show/NCT01358877?term=BO25126&rank=1